Condition: Gout · Sponsor: Protalix
This is a multicenter, randomized, double-blind, placebo-controlled phase II study assessing the efficacy, safety, and dosing regimen selection of multiple IV infusions of PRX-115 over 24 weeks, with or without MTX, versus the respective placebos in adult patients with gout.
This description comes directly from the study's public registry record.
Head of Clinical Development · +972-4-902-8100 · info@protalix.com
Always discuss trial participation with your own doctor first.
| Applied Research Center of Arkansas | Little Rock, Arkansas, United States | Recruiting |
| Triwest Research Associates Llc | El Cajon, California, United States | Recruiting |
| Clinical Research of West Florida, Inc. | Clearwater, Florida, United States | Recruiting |
| Accel Research Sites - Deland Clinical Research Unit | DeLand, Florida, United States | Recruiting |
| ICR Sites East | Doral, Florida, United States | Recruiting |
| Qway Research | Hialeah, Florida, United States | Recruiting |
| Bioclinical Research Alliance, Inc | Miami, Florida, United States | Recruiting |
| D&H National Research Centers (North Miami) | Miami, Florida, United States | Recruiting |
| Well Pharma Medical Research Group | Miami, Florida, United States | Recruiting |
| Conquest Research - Lake Nona | Orlando, Florida, United States | Recruiting |
| Combined Research Orlando Phase I-IV | Orlando, Florida, United States | Recruiting |
| New Horizons Research | Palmetto Bay, Florida, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07280156